Skip to content

Press Release Details

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022

Jan 5, 2022

BOSTON, Jan. 5, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, February 8, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on February 8, 2022

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1649685

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:

A replay of the conference call and webcast will be available for one year beginning on February 8, 2022 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit

Investor Contact:                                

Media Contact:

Olga Guyette, Director-Investor Relations

Josh Gitelson, Director-Global Communications

(781) 356-9763

(781) 356-9776


Cision View original content to download multimedia:

SOURCE Haemonetics Corporation